A Phase I Study of PM02734 in Subjects With Advanced Malignant Solid Tumors
NCT00404521
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
56
Enrollment
INDUSTRY
Sponsor class
Stopped
Low rate recruitment
Conditions
Solid Tumors
Interventions
DRUG:
PM02734
Sponsor
PharmaMar